Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min-Reference-Cited by-同舟云学术

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

Published:2019-11-14 Issue:11 Volume:14 Page:e0225199
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ross Lisa L.^ORCID,Walker A. Sarah,Lou Yu,Tenorio Allan R.,Gibb Diana M.,Double Julia,Gilks Charles,McCoig Cynthia C.,Munderi Paula,Musoro Godfrey,Kityo Cissy M.,Grosskurth Heiner,Hakim James,Mugyenyi Peter N.,Cutrell Amy,Perger Teodora,Shaefer Mark S.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference13 articles.

1. Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction;AE Heald;Antimicrob Agents Chemother,1996

2. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts <200 cells/microl;DART Trial Team;AIDS,2008

3. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial;DART Trial Team;Lancet,2010

4. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification;AS Levey;Ann Intern Med,2003

5. Prediction of creatinine clearance from serum creatinine;D Cockcroft;Nephron,1976

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

3. Antiretrovirals for People with HIV on Dialysis;AIDS Patient Care and STDs;2022-03-01